Skip To Main Content
Contact us
|
Help
Home
About
ADR
ADR Archives
Resources
Contact
Flash e-reader
Choose a chapter:
Introduction
Kidney
Pancreas
Liver
Intestine
Heart
Lung
Deceased Organ Donation
Allocation Policies
Appendix
Table Selection
Choose an organ:
All Organs
Kidney
Pancreas
Kidney/Pancreas
Heart
Lung
Heart/Lung
Intestine
Liver
Choose a group:
Choose a characteristic:
Requires
Adobe Acrobat Reader
Table 9.12a
Adjusted Patient Survival, Deceased Donor Liver Transplants
Survival at 3 Months, 1 Year, 5 Years, and 10 Years
3 Months
1 Year
5 Years
10 Years
(Tx 2007 - 2008)
(Tx 2007 - 2008)
(Tx 2003 - 2008)
(Tx 1998 - 2008)
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
Total
All
10,369
94.6%
0.2%
10,369
89.1%
0.3%
30,505
73.7%
0.3%
50,506
59.9%
0.3%
Transplant Center State
Alabama
190
95.8%
1.4%
190
90.6%
2.1%
498
77.4%
2.3%
916
63.9%
2.2%
Arkansas
50
96.2%
2.6%
50
94.3%
3.2%
89
86.0%
4.9%
89
86.0%
4.9%
Arizona
212
96.7%
1.2%
212
91.1%
1.9%
486
77.2%
2.4%
688
61.6%
3.4%
California
1,182
94.9%
0.6%
1,182
89.6%
0.9%
3,524
75.7%
0.9%
6,081
63.8%
0.9%
Colorado
156
94.3%
1.8%
156
88.6%
2.5%
448
80.4%
2.3%
751
70.8%
2.5%
Connecticut
75
93.1%
2.9%
75
87.6%
3.8%
177
73.7%
4.0%
325
59.9%
3.7%
District of Columbia
109
93.5%
2.4%
109
91.6%
2.7%
300
72.1%
3.2%
436
62.1%
3.2%
Delaware
7
77.7%
18.3%
7
57.7%
21.1%
31
62.8%
12.1%
47
71.3%
9.2%
Florida
1,011
96.4%
0.6%
1,011
90.3%
0.9%
2,904
75.5%
1.0%
4,869
61.5%
1.1%
Georgia
257
95.6%
1.3%
257
90.0%
1.9%
668
66.9%
2.4%
1,011
53.1%
2.6%
Hawaii
25
92.6%
4.9%
25
89.0%
5.9%
74
72.6%
6.0%
122
70.6%
5.0%
Iowa
45
97.9%
2.0%
45
95.8%
2.9%
141
85.4%
3.3%
327
62.8%
3.9%
Illinois
366
91.2%
1.5%
366
83.8%
1.9%
1,217
71.0%
1.4%
2,029
56.7%
1.6%
Indiana
220
95.2%
1.4%
220
88.6%
2.1%
785
73.0%
1.9%
1,122
56.9%
2.9%
Kansas
122
94.4%
2.0%
122
93.7%
2.2%
265
78.7%
3.6%
427
61.9%
3.7%
Kentucky
152
91.7%
2.2%
152
85.3%
2.8%
465
72.0%
2.4%
716
59.6%
2.8%
Louisiana
247
96.1%
1.2%
247
92.6%
1.6%
777
74.2%
1.8%
1,265
58.1%
2.1%
Massachusetts
200
90.6%
2.0%
200
84.6%
2.5%
669
70.8%
2.0%
1,218
56.9%
2.0%
Maryland
175
92.1%
2.0%
175
79.0%
3.1%
448
62.9%
2.7%
705
53.7%
2.7%
Michigan
327
96.4%
1.0%
327
90.7%
1.6%
923
74.1%
1.7%
1,457
60.9%
2.0%
Minnesota
225
94.3%
1.5%
225
89.9%
2.0%
688
76.7%
1.9%
1,248
64.7%
2.0%
Missouri
255
94.0%
1.5%
255
89.2%
2.0%
720
74.3%
2.1%
1,130
61.9%
2.1%
North Carolina
226
93.9%
1.6%
226
85.7%
2.3%
646
71.3%
2.1%
1,167
59.5%
2.0%
Nebraska
129
96.1%
1.7%
129
89.9%
2.7%
429
76.4%
2.3%
807
64.2%
2.2%
New Jersey
127
97.0%
1.5%
127
91.7%
2.4%
428
75.2%
2.3%
768
64.3%
2.3%
New Mexico
0
-
-
0
-
-
0
-
-
27
65.4%
9.1%
New York
753
91.9%
1.0%
753
85.2%
1.3%
2,470
65.0%
1.2%
3,870
54.2%
1.2%
Ohio
429
95.8%
1.0%
429
91.4%
1.3%
1,198
72.1%
1.7%
1,883
58.9%
1.7%
Oklahoma
107
94.7%
2.1%
107
92.1%
2.5%
331
78.8%
2.6%
563
69.3%
3.0%
Oregon
103
100.0%
0.0%
103
93.6%
2.3%
281
83.4%
2.5%
508
62.8%
3.2%
Pennsylvania
749
94.7%
0.8%
749
87.6%
1.2%
2,392
70.9%
1.1%
4,103
54.8%
1.2%
South Carolina
111
93.1%
2.4%
111
87.0%
3.1%
282
79.6%
2.9%
554
54.1%
3.2%
Tennessee
360
94.9%
1.1%
360
90.6%
1.5%
817
73.0%
2.1%
1,257
58.2%
2.2%
Texas
923
94.9%
0.7%
923
90.5%
1.0%
2,709
75.7%
1.0%
4,362
60.9%
1.2%
Utah
110
95.3%
2.0%
110
89.6%
3.0%
308
81.3%
2.6%
493
68.1%
3.7%
Virginia
217
92.5%
1.7%
217
88.5%
2.1%
563
76.6%
2.1%
931
51.6%
2.7%
Washington
191
97.9%
1.0%
191
93.6%
1.8%
664
78.1%
1.9%
1,035
59.7%
2.7%
Wisconsin
226
92.6%
1.7%
226
87.7%
2.2%
690
76.9%
1.9%
1,199
61.5%
2.2%
Source: OPTN/SRTR Data as of October 1, 2010.
(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.
Cohorts are transplants performed during the years listed at the top of the table.
Patient survival follows patients from first transplant of this type until death.
Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.
Center volume = Center's yearly transplants performed during the base period, based on liver transplants.
Multi-organ transplants are excluded.
Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.